Search company, investor...

Genera Biosystems

generabiosystems.com

Stage

Other Investors | Alive

About Genera Biosystems

Genera Biosystems is a development phase company that designs, develops and produces and clinically effective human molecular diagnostics with a focus on women's health.

Headquarters Location

1 Dalmore Drive, Small Technologies Cluster

3179,

Australia

Missing: Genera Biosystems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Genera Biosystems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Genera Biosystems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Genera Biosystems is included in 1 Expert Collection, including Women's Health & Wellness.

W

Women's Health & Wellness

1,482 items

Startups focused on providing products and services catering to women's health and wellbeing.

Genera Biosystems Patents

Genera Biosystems has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/4/2012

8/22/2017

Molecular biology, Monoclonal antibodies, Inflammations, Glucocorticoids, Syndromes

Grant

Application Date

10/4/2012

Grant Date

8/22/2017

Title

Related Topics

Molecular biology, Monoclonal antibodies, Inflammations, Glucocorticoids, Syndromes

Status

Grant

Latest Genera Biosystems News

Genera Biosystems Ltd GBI Product Pipeline Analysis 2019 Update Published by Global Data Prices from USD $638

Jan 22, 2020

Genera Biosystems Ltd GBI Product Pipeline Analysis, 2019 Update [Published by Global Data] Prices from USD $638 12:53 EST 22 Jan 2020 | BioPortfolio Reports Summary Genera Biosystems Ltd GBL is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is a molecular diagnostic test for the detection and genotyping of high risk and low risk types of human papillomavirus that cause cervical cancer or genital warts. GBL uses AmpaSand beads technology to create identifiable clusters of beads that can be distinguished in a conventional flow cytometer. The company provides products to detect influenzaA, influenzaB, influenza A H1N1, influenzaA H5N1, respiratory syncytial virus, human metapneumovirus, adenovirus, rhinovirus, bordetella pertussis, and chlamydophila pneumonia. It collaborates with pathology customers and IVD companies. GBL is headquartered in Melbourne, Victoria, Australia. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company Genera Biosystems Ltd The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research Development strategies Develop marketentry and market expansion strategies Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Related Biotechnology, Pharmaceutical and Healthcare News

Genera Biosystems Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Genera Biosystems Rank

Genera Biosystems Frequently Asked Questions (FAQ)

  • What is Genera Biosystems's latest funding round?

    Genera Biosystems's latest funding round is Other Investors.

  • Who are the investors of Genera Biosystems?

    Investors of Genera Biosystems include Queensland BioCapital Funds.

  • Who are Genera Biosystems's competitors?

    Competitors of Genera Biosystems include Linkage Biosciences, Aviir, VitaPath Genetics, Navigenics, MicroPhage and 11 more.

Compare Genera Biosystems to Competitors

Aviir Logo
Aviir

Aviir discovers, develops and commercializes diagnostic laboratory tests employing the latest technologies with a focus on cardiovascular disease along with related metabolic disorders. Beyond these novel tests, an extensive menu of standard of care cardiovascular & metabolic tests are provided through the company's CLIA certified laboratory. Aviir's MIRISK and MIRISK VP assessments objectively identify, using a single blood draw, individuals who are at a high risk of experiencing a cardiac event over the next five years.

M
MicroPhage

MicroPhage's mission is to be a worldwide pioneer in rapid bacterial diagnostics, in both bacterial identification and antibiotic susceptibility/resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics.

3
3PrimiR

3PrimiR is researching how mutations in micro RNA molecules can be used in cancer diagnostics.

H
Helix Diagnostics

Helix Diagnostics LLC is pursuing development and commercialization of multiplexed DNA detection systems based on capillary electrophoresis.

V
Viridis Diagnostics

Viridis' equipment is a disease marker testing platform to be used at point-of-care.

Life Line Screening Logo
Life Line Screening

Life Line Screening offers preventive health screening services for stroke, abdominal aortic aneurysm, peripheral arterial disease, diabetes, heart disease & osteoporosis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.